Melissa Palmer

Melissa Palmer

Directeur Technique/Scientifique/R&D chez CYTODYN INC.
Health Technology
Consumer Services
Health Services

Profil

Melissa Palmer is currently the Chief Medical Officer at CytoDyn, Inc. She previously worked as the Hepatology Director at New York University.
In 2019, she was the Head-Liver Disease Clinical Development at Takeda Pharmaceutical Co., Ltd. From 2020 to 2022, she served as the Chief Medical Officer at Ascletis Pharma, Inc. and Gannex Pharma Co Ltd. Dr. Palmer is also a Professor at NYU Langone Health.
She completed her undergraduate degree at The Trustees of Columbia University in The City of New York and obtained her doctorate from Icahn School of Medicine at Mount Sinai.

Postes actifs de Melissa Palmer

SociétésPosteDébut
CYTODYN INC. Directeur Technique/Scientifique/R&D 24/05/2023

Anciens postes connus de Melissa Palmer

SociétésPosteFin
Directeur Technique/Scientifique/R&D 01/03/2022
ASCLETIS PHARMA INC. Directeur Technique/Scientifique/R&D 01/03/2022
TAKEDA PHARMACEUTICAL COMPANY LIMITED Corporate Officer/Principal 01/08/2019
Corporate Officer/Principal -
Corporate Officer/Principal -
Voir l'expérience en détail de Melissa Palmer

Formation de Melissa Palmer

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

35

Relations au 1er degré

8

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées8

Health Technology

Consumer Services

Health Technology

Consumer Services

Consumer Services

Health Services

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Melissa Palmer